MARKET

ACHV

ACHV

Achieve Life Sciences Inc
NASDAQ
6.10
-0.01
-0.16%
After Hours: 6.11 +0.01 +0.16% 18:55 07/13 EDT
OPEN
6.06
PREV CLOSE
6.11
HIGH
6.17
LOW
5.95
VOLUME
1.33M
TURNOVER
--
52 WEEK HIGH
7.11
52 WEEK LOW
2.371
MARKET CAP
626.22M
P/E (TTM)
-5.4817
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ACHV last week (0706-0710)?
Weekly Report · 17h ago
Achieve Life Sciences: Despite CRL, A Success Is Achieve-Able
Seeking Alpha · 6d ago
Achieve Life Sciences Expands Authorized Shares After Stockholder Vote
TipRanks · 07/06 20:33
Achieve Life Sciences shareholders approve authorized common stock increase to 300 million shares at annual meeting
PUBT · 07/06 20:07
Weekly Report: what happened at ACHV last week (0629-0703)?
Weekly Report · 07/06 09:15
Achieve Life Sciences added to Russell 2000 Index
TipRanks · 06/29 13:00
Achieve Life Sciences Added To Russell 2000 Index, Effective June 26
Benzinga · 06/29 12:38
ACHIEVE LIFE SCIENCES JOINS RUSSELL 2000® INDEX
Reuters · 06/29 12:30
More
About ACHV
Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company. The Company focuses on addressing the global smoking health and nicotine dependence epidemic through the development and commercialization of cytisinicline. It has completed two Phase III studies with cytisinicline for smoking cessation and one Phase II study with cytisinicline in vaping cessation. Cytisinicline is a naturally occurring, plant-based alkaloid. Cytisinicline is structurally similar to nicotine and has a dual-acting mechanism of action, being both a receptor agonist and antagonist. Cytisinicline is an investigational product candidate being developed for the treatment of nicotine dependence and has not been approved by the Food and Drug Administration for any indication in the United States. Cytisinicline acts as a partial agonist/antagonist, binding to alpha-4 beta-2 nicotinic receptors in the brain and is thought to have two potential consequences in treating nicotine dependence.

Webull offers Achieve Life Sciences Inc stock information, including NASDAQ: ACHV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACHV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACHV stock methods without spending real money on the virtual paper trading platform.